M Talamonti Selected Research

M Talamonti Research Topics

24	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020 - 04/2007
4	Atopic Dermatitis (Atopic Eczema) 04/2021 - 01/2019
2	COVID-19 01/2021 - 12/2020
2	Obesity 11/2019 - 07/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2017 - 12/2016
2	Nasopharyngitis 06/2017 - 12/2016
2	Arthralgia (Joint Pain) 06/2017 - 12/2016
2	Headache (Headaches) 06/2017 - 12/2016
1	Eczema 01/2020
1	Exanthema (Rash) 01/2020
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Dermatitis 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2018
1	Candidiasis (Moniliasis) 07/2018
1	Infections 02/2018
1	Bacterial Infections (Bacterial Infection) 02/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2013
1	Psoriatic Arthritis 01/2012
1	Progressive Multifocal Leukoencephalopathy 01/2011
1	Necrosis 01/2009
1	Heart Failure 04/2007
1	Skin Diseases (Skin Disease) 04/2007
1	Carcinoma (Carcinomatosis) 05/2001
1	Neoplasms (Cancer) 05/2001

7	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 01/2010
6	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2017
5	Biological ProductsIBA 01/2020 - 04/2007
4	secukinumabIBA 01/2020 - 09/2018
4	Adalimumab (Humira)FDA Link 10/2018 - 01/2009
4	Pharmaceutical PreparationsIBA 02/2018 - 01/2011
3	ixekizumabIBA 01/2020 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2001
3	brodalumabIBA 01/2019 - 12/2016
3	efalizumab (Raptiva)FDA Link 01/2011 - 04/2007
3	Etanercept (Enbrel)FDA Link 04/2010 - 01/2009
2	dupilumabIBA 04/2021 - 08/2020
2	Monoclonal AntibodiesIBA 11/2019 - 04/2007
2	Interleukin-23 (Interleukin 23)IBA 11/2019 - 07/2018
2	InterleukinsIBA 11/2019 - 07/2018
2	Interleukin-12 (IL 12)IBA 11/2019 - 08/2013
2	CytokinesIBA 11/2019 - 07/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 10/2018
2	HLA-C Antigens (HLA-C)IBA 08/2017 - 01/2016
2	Infliximab (Remicade)FDA Link 01/2010 - 01/2009
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Interleukin-17 ReceptorsIBA 11/2019
1	Interleukin-23 Subunit p19IBA 07/2018
1	guselkumabIBA 07/2018
1	Interleukin-22 (IL-22)IBA 07/2018
1	dalbavancinIBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 07/2016
1	Adenosine Triphosphate (ATP)IBA 07/2016
1	tofacitinibIBA 07/2016
1	Oligonucleotide ProbesIBA 01/2016
1	HLA-C*06 antigenIBA 08/2013
1	ametantrone (HAQ)IBA 01/2012
1	C-Reactive ProteinIBA 01/2012
1	amsonic acid (DAS)IBA 01/2012
1	SuspensionsIBA 01/2011
1	Tumor Necrosis Factor InhibitorsIBA 01/2009
1	Alefacept (Amevive)FDA Link 01/2009
1	Thymidylate SynthaseIBA 05/2001

7	Biological Therapy 12/2020 - 04/2007
6	Therapeutics 04/2021 - 04/2007
1	Ambulatory Care (Outpatient Care) 02/2018
1	Complementary Therapies (Alternative Medicine) 01/2011
1	Drug Therapy (Chemotherapy) 05/2001